VBL Therapeutics

VBL Therapeutics is a company listed under the stock ticker VBLT (IL).

Acquisition, funding and merger involving VBL Therapeutics.

• VBL Therapeutics and Notable Labs have announced they will merge  (posted on February 24 2023)..

View the org chart displaying its 9 main executives

Most searched biographies at VBL Therapeutics

• Dror Harats, Chief Executive Officer and Director
• David Hastings, Director
• Ruti Alon, Director

Create your alert
to follow the executive moves at VBL Therapeutics.

VBL Therapeutics has 2,284 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Karius has just announced a $100 Million fundraising (posted on May 3 2024).
• Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
• WindRose Health Investors has announced the acquisition of SubjectWell  (posted on May 2 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by VBL Therapeutics

• VBL Therapeutics Announces Results of Annual and Special Shareholder Meeting | VBL Therapeutics
• VBL Therapeutics Reminds Shareholders to Vote in the Upcoming Annual and Special Shareholder Meeting | VBL Therapeutics
• VBL Therapeutics Announces that S-4 Registration Statement for Proposed Merger with Notable Labs Is Declared Effective by SEC | VBL Therapeutics
• VBL Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update | VBL Therapeutics
• VBL Therapeutics Announces Workforce Reduction | VBL Therapeutics
• VBL Therapeutics Announces Top-Line Data from Phase 3 OVAL Trial of Ofra-Vec in Patients with Platinum-Resistant Ovarian Cancer | VBL Therapeutics
• VBL Therapeutics to Participate in the Jefferies Healthcare Conference | VBL Therapeutics
• VBL Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update | VBL Therapeutics
• VBL Therapeutics to Report First Quarter 2022 Financial Results on May 17 | VBL Therapeutics
• VBL Therapeutics to Participate in Upcoming Scientific and Industry Conferences in May | VBL Therapeutics
• View more press releases Close

Social media about VBL Therapeutics

• VBL Therapeutics on Wikipedia, Google News & Yahoo Finance
• VBL Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Dror Harats

Call VBL Therapeutics at +972 ...

View the org chart

Register to receive your alert

Report an error